Liver SBRT: Primary and Oligometastatic

Liver SBRT: Primary and Oligometastatic Disease

Comprehensive Lecture Summary

1. Main Clinical Topics Discussed

• Role of stereotactic body radiation therapy (SBRT) / stereotactic ablative body radiation therapy (SABR) in hepatocellular carcinoma (HCC) and oligometastatic liver disease
• Comparison of liver-directed local therapies (SBRT, RFA, TACE, Y-90 radioembolization, HAI)
• Advances in radiation delivery technology and image guidance
• Multidisciplinary integration of liver-directed therapies
• Acute and chronic toxicity considerations relevant to sequential therapy planning

2. Key Learning Points, Guidelines, and Recommendations

Treatment Hierarchy in HCC:

• Liver transplantation and surgical resection remain the gold standard for durable outcomes in HCC
• However, only a minority of patients are eligible for curative surgery or transplant
• Local therapies (SBRT, RFA, TACE, Y-90, cryoablation, IRE, HAI) constitute the primary management landscape for the majority of patients

SBRT vs. Conventional Radiation:

• SBRT delivers high dose per fraction over 1–5 fractions, enabling ablative dosing with tight tumor margins
• Conventional radiotherapy typically spans 25–40 fractions, preferred when bowel is adjacent, liver reserve is limited, or advanced technology is unavailable
• SBRT allows treatment of larger tumors than historically assumed possible with radiation

Y-90 Radioembolization vs. SBRT:

• Y-90 resin/glass beads penetrate only a few millimeters into tissue, risking marginal misses in hypovascular, fibrotic, or infiltrative tumors
• A proposed future paradigm: Y-90 followed by SBRT boost to regions of suspected underdosing — particularly at tumor margins
• Y-90 can now achieve higher tumor doses in select settings, but toxicity tradeoffs must be considered

Radiation Technology Advances:

• IMRT (Intensity-Modulated Radiation Therapy): Real-time beam modulation for conformal dose delivery
• Proton therapy / Carbon ion therapy: Exploit the Bragg peak to concentrate dose within the tumor while sparing surrounding parenchyma — especially valuable for central lesions, re-irradiation, and patients with limited hepatic reserve
• MR-guided adaptive radiotherapy: Real-time tumor visualization enabling tighter margins, adaptive replanning within seconds, and reduced normal tissue dose
• Fiducial markers: Typically 2–3 gold fiducials placed adjacent to (not within) the tumor to minimize seeding risk, reduce CT artifact, and improve spatial co-localization
• Spacers: Can be placed between tumor and adjacent bowel to facilitate ablative dosing
• Respiratory motion management: Active breathing control (breath-hold gating) using surface monitoring (e.g., RPM system with chest block) — patients visually coached to maintain breath-hold within a defined window during simulation and treatment

Hepatic Arterial Infusion (HAI):

• Growing use of intraarterial 5-FU pump therapy for systemic hepatic progression control
• Clinicians should anticipate patients presenting with focal progression amid stable background disease — requiring targeted local salvage therapy

3. Clinical Data, Statistics, or Study Results Cited

> Note: This lecture was largely conceptual and technology-focused. The speaker did not cite specific published trials, numeric outcomes, or named studies in the portion of the transcript provided. Quantitative data (e.g., local control rates, survival endpoints, toxicity rates) were not detailed in this segment.

• Implicit reference to evolving Y-90 dosimetry improving outcomes compared to historical standards
• Reference to radiomics and functional MRI/PET as emerging tools for non-invasive response assessment
• Mention of a 1440 Foundation grant supporting a learning health network for pancreatic cancer (disclosed as unrelated)
• Disclosures: consulting/protocol development with Boston Scientific, BTG, and Histosonics

4. Practical Takeaways for Clinicians

• Radiation has evolved substantially — concerns about skin burns, rib toxicity, and collateral liver damage reflect outdated paradigms; modern